Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy

✍ Scribed by Carlos Rodrigo Zárate- Bladés; Vânia Luiza Deperon Bonato; Eduardo Lani Volpe da Silveira; Marina Oliveira e Paula; Cristina Moraes Junta; Paula Sandrin-Garcia; Ana Lúcia Fachin; Stephano Spanó Mello; Renato Sousa Cardoso; Fábio Cícero de Sá Galetti; Arlete Aparecida Martins Coelho-Castelo; Simone Gusmão Ramos; Eduardo Antonio Donadi; Elza Tiemi Sakamoto-Hojo; Geraldo Aleixo da Silva Passos; Celio Lopes Silva

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 395 KB
• Volume: 11
• Category: Article
• ISSN: 1099-498X
• DOI: 10.1002/jgm.1269

✦ Synopsis

Abstract

Background

The continued increase in tuberculosis (TB) rates and the appearance of extremely resistant Mycobacterium tuberculosis strains (XDR‐TB) worldwide are some of the great problems of public health. In this context, DNA immunotherapy has been proposed as an effective alternative that could circumvent the limitations of conventional drugs. Nonetheless, the molecular events underlying these therapeutic effects are poorly understood.

Methods

We characterized the transcriptional signature of lungs from mice infected with M. tuberculosis and treated with heat shock protein 65 as a genetic vaccine (DNAhsp65) combining microarray and real‐time polymerase chain reaction analysis. The gene expression data were correlated with the histopathological analysis of lungs.

Results

The differential modulation of a high number of genes allowed us to distinguish DNAhsp65‐treated from nontreated animals (saline and vector‐injected mice). Functional analysis of this group of genes suggests that DNAhsp65 therapy could not only boost the T helper (Th)1 immune response, but also could inhibit Th2 cytokines and regulate the intensity of inflammation through fine tuning of gene expression of various genes, including those of interleukin‐17, lymphotoxin A, tumour necrosis factor‐α, interleukin‐6, transforming growth factor‐β, inducible nitric oxide synthase and Foxp3. In addition, a large number of genes and expressed sequence tags previously unrelated to DNA‐therapy were identified. All these findings were well correlated with the histopathological lesions presented in the lungs.

Conclusions

The effects of DNA therapy are reflected in gene expression modulation; therefore, the genes identified as differentially expressed could be considered as transcriptional biomarkers of DNAhsp65 immunotherapy against TB. The data have important implications for achieving a better understanding of gene‐based therapies. Copyright © 2008 John Wiley & Sons, Ltd.